Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

250 Views

Poster Session: Antimicrobial Resistance Mechanisms

150 - Low Propensity for Development of Spontaneous In Vitro Resistance to Tebipenem, Ertapenem and Meropenem Among Enterobacterales Uropathogens

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Brian D. VanScoy, B.S.

Director
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States

Co-Author(s)

HC

Haley Conde, B.S.

Laboratory Manager
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
RM

Rodrigo E. Mendes, PhD

JMI Laboratories
North Liberty, Iowa, United States
NC

Nicole Cotroneo, B.S.

Director
Spero Therapeutics
Cambridge, Massachusetts, United States
Ian A. Critchley, PhD

Vice President, Head
Spero Therapeutics
Cambridge, Massachusetts, United States